CODX (NASDAQ:CODX) is making a strategic push to scale its global diagnostics platform, announcing a major expansion of ...
Joe Reader is running the London Marathon to raise awareness for Coeliac UK and help fund crucial research which could lead to more diagnoses.
The boss of Yorkshire-based lateral flow test developer Abingdon Health has said the company is still benefiting after the pandemic turned a once rarely discussed product into a household name.
Researchers are seeking pregnant patients for the clinical trial of a drug designed to decrease the risk of fetal anemia in patients with hemolytic disease of the fetus and newborn (HDFN).
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
Discover how Ovine Johne’s Disease affects UK flocks, its hidden spread, key signs, and the biosecurity steps that help protect sheep health.
Background Adalimumab is an effective first-line biologic therapy used to treat children and young people (CYP) with juvenile idiopathic arthritis (JIA) and non-infectious uveitis (NIU). However, the ...
JCV is a DNA polyomavirus and the primary aetiological agent of PML. Most adults carry JCV in its latent form, but the virus ...
Up to 30% of children with juvenile arthritis develop uveitis, an eye inflammation that can damage vision. New research highlights immune cells as treatment targets.
A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results